Skip to main content
All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG · global pharmaceutical company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000.00 income · posted Apr 21, 2025

Official filing document

 Lobbying activity 2
Medicare/Medicaid

General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals.

Health Issues

General education about end stage renal disease (ESRD) and kidney disease policies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem